Introduction {#sec1}
============

New applications of near-infrared (NIR) dyes have sparked recent interest in these substances with strong NIR absorption, proving an important and useful phenomenon. While fluorescence is particularly applicable to labeling in microscopy,^[@ref1]^ organic molecules with eminent NIR absorption have attracted interest owing to the wide range of applications for their optical and electronic properties.^[@ref2],[@ref3]^ Nowadays, nonmetallic organic dyes have many potential advantages, such as being lightweight, low-cost, and easily processed with colorful and transparent features. These classical metal-free NIR organic dyes^[@ref4]^ include squaraines,^[@ref5]^ cyanines,^[@ref6]^ and the particularly well-known rhodamines,^[@ref7]^ boron-dipyrromethenes^[@ref8]^ and diketopyrrolopyrroles^[@ref9]^ ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). These structures have received increasing attention from both industry and academic research. However, the range of the reported NIR dye molecular skeletons is limited, making the development of novel NIR dye core structures highly desirable. Although NIR chromophores constructed from novel nitrogen-containing polyheterocycles^[@ref10],[@cit11e]^ have been discovered recently, methods for obtaining these desired NIR dyes have yet to be established. One such approach to obtaining the desired NIR dyes is through the discovery of novel chromophores.

![Metal-free NIR absorption chromophores.](ao-2019-00315f_0001){#fig1}

In our search for a novel and efficient ruthenium-catalyzed one-pot reaction involving both metathesis and nonmetathesis reactions,^[@ref11],[@ref12]^ we previously developed a one-pot ring-closing metathesis (RCM)/oxidation/1,3-dipolar cycloaddition protocol to prepare various isoindolo\[2,1-*a*\]quinolines **3** from *N*-allyl-2-alkenylaniline derivatives **1** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).^[@ref13]^ The key intermediate in this reaction is likely to be azomethine ylide **I** derived from 1,2-dihydroquinoline **2**.

![Our Previous Work: One-Pot Ring-Closing Metathesis (RCM)/Oxidation/1,3-Dipolar Cycloaddition Protocol](ao-2019-00315f_0013){#sch1}

The isoindolo\[2,1-*a*\]quinoline motif ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}) is attractive because of its biological properties.^[@ref14]^ For instance, 5,11-dioxoisoindolo\[2,1-*a*\]quinolines are analogs of berberine alkaloids that have been shown to have an inhibitory effect against N~2~-induced hypoxia^[@cit14a]^ and inhibit human topoisomerase II.^[@cit14b]^ Meanwhile, 7,10-dioxoisoindolo\[2,1-*a*\]quinolines, first synthesized by our group,^[@ref13]^ are functional dyes. In particular, we found that compound **3** showed a variety of colors when exchanging the R^1^ substituent (R^1^ = Ph, Me), including blue, yellow, and red ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"} and [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}), despite the core structure of **3** being the same as that of the 7,10-dioxoisoindolo\[2,1-*a*\]quinoline system.

![Structures of isoindolo\[2,1-*a*\]quinolines.](ao-2019-00315f_0005){#fig2}

![Colors of compounds **3a--c** (500 μM in toluene).](ao-2019-00315f_0006){#fig3}

Blue compound **3a** ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}), which bears a methyl substituent at the 5-position of isoindolo\[2,1-*a*\]quinoline, clearly showed absorption peaks in the NIR region with a maximum at 673--720 nm ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). In contrast, the maximal absorption wavelengths of yellow compound **3b** and red compound **3c** containing phenyl substituents at the 5-position absorbed at 447--452 nm and 477--494 nm, respectively.

![Absorption spectra of compounds **3a--c** (200--900 nm; 50 μM in CHCl~3~).](ao-2019-00315f_0007){#fig4}

Considering that the chemical yield of 5-methylisoindolo\[2,1-*a*\]quinoline **3a** from corresponding precursor **1a** was low, and that **3a** was a novel metal-free NIR absorption dye, we decided to optimize the synthetic conditions to afford **3a** and synthesize 5-methylisoindolo\[2,1-*a*\]quinoline derivatives **3** with different substituents on the aromatic ring to better understand the relationship between the structure and NIR absorption. We also performed theoretical calculation of the newly synthesized 5-methylisoindolo\[2,1-*a*\]quinoline derivatives **3** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).

![This Work: Synthesis, Absorbance Properties, and Theoretical Calculation of 5-Methylisoindolo\[2,1-*a*\]quinolines **3**](ao-2019-00315f_0014){#sch2}

Results and Discussion {#sec2}
======================

*N*-Allyl-*N*-benzylaniline derivatives **1** were prepared systematically and efficiently. Our tandem catalysis strategy was first investigated using *N*-allyl-*N*-benzylaniline derivatives **1a**, 1,4-benzoquinone, and ruthenium carbene catalysts. We first optimized the reaction conditions of the one-pot reaction, as shown in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. Entries 2--4 show that a higher loading of the Grubbs II catalyst (20 mol %) was not effective, with a 1 mol % loading proving sufficient for this one-pot reaction. Furthermore, benzene was successfully substituted with less-toxic toluene as the solvent (entry 5), affording **3a** in 18% yield in a shorter reaction time of 10 min (entry 6). We next optimized the reaction concentration. When the one-pot reaction was performed in a 0.1 M solution, **3a** was obtained in 5% yield with a cross metathesis product obtained in 28% yield (entry 7). The chemical yield of **3a** was not improved under glovebox conditions (entry 8). We next applied these optimal conditions (entry 6) to the synthesis of substituted derivatives of 5-methylisoindolo\[2,1-*a*\]quinoline **3**.

###### Optimization of the One-Pot RCM/Oxidation/1,3-Dipolar Cycloaddition Protocol

![](ao-2019-00315f_0017){#GRAPHIC-d7e550-autogenerated}

                                           RCM       1,3-dipolar cycloaddition   isolated yield                             
  ----------------------------------- ---- --------- --------------------------- ---------------- ---- -------- ------ ---- ----
  1                                   10   benzene   reflux                      0.01             30   reflux   0.01   60   15
  2                                   20   benzene   reflux                      0.01             30   reflux   0.01   60   11
  3                                   5    benzene   reflux                      0.01             30   reflux   0.01   60   16
  4                                   1    benzene   reflux                      0.01             30   reflux   0.01   60   18
  5                                   1    toluene   80                          0.01             30   80       0.01   60   18
  6                                   1    toluene   80                          0.01             10   80       0.01   30   18
  7[a](#t1fn1){ref-type="table-fn"}   1    toluene   80                          0.1              10   80       0.1    30   5
  8[b](#t1fn2){ref-type="table-fn"}   1    toluene   80                          0.01             10   80       0.01   30   15

Cross metathesis product was also isolated in 28% yield.

Reaction was performed in a glovebox.

Experiments performed to establish the substrate scope are summarized in [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}. The RCM of **1** proceeded quantitatively, as determined by thin layer chromatography (TLC) analysis, regardless of the substituent attached to the aromatic ring. However, 1,3-dipolar cycloaddition and oxidation were affected by the substituent on the aromatic ring. Therefore, the electronic effects of substituents on the aromatic ring were responsible for the substrate reactivity toward 1,3-dipolar cycloaddition. Higher yields of one-pot reaction products **3d**, **3e**, **3f**, **3g**, and **3h** were obtained using substrates with an electron-withdrawing group on the aromatic ring. 3,5-Dimethylisoindolo\[2,1-*a*\]quinoline (**3j**) was synthesized in 17% yield. Although generation of **3i** and **3k** was observed by TLC, these products were unstable and decomposed during purification. Naphthylamine derivative **1l** was also converted to pentacyclic compound **3l** in 44% yield. 1,4-naphthoquinone was also used as a 1,3-dipolarophile in the reaction, affording pentacyclic compound **3m**. We also synthesized **3n** and **3o** from the corresponding precursor in 6 and 12% yields, respectively.

![Scope of One-Pot RCM/Oxidation/1,3-Dipolar Cycloaddition Protocol](ao-2019-00315f_0015){#sch3}

The all-obtained isoindolo\[2,1-*a*\]quinolines **3** were blue-colored solids. The color of the solution of compound **3** in CHCl~3~ is shown in the [Supporting Information S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00315/suppl_file/ao9b00315_si_002.pdf) (Figure S1). Compounds **3d--3h** containing electron-withdrawing groups formed blue-colored solutions in CHCl~3~. Meanwhile, solutions of methyl-substituted tetracyclic compound (**3j**) and benzo\[*g*\]isoindolo\[2,1-*a*\]quinoline (**3l**) were light-green to green in color. The solution of **3m** in CHCl~3~, synthesized from **1f** and 1,4-naphtoquinone, had a deep blue color. The color of a solution of **3n** and **3o** in CHCl~3~ was blue.

We then investigated the absorption profiles of compounds **3** in CHCl~3~ ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}) and in MeOH ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}). The maximal absorption wavelengths (λ~ex~) and molar absorption coefficients (ε) of compounds **3** are shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. Except for **3l**, all compounds **3** showed similar absorption spectra in the visible region in CHCl~3~. The maximal absorption wavelength of **3d**, with a chloride substituent at the 4-position of the isoindolo\[2,1-*a*\]quinoline, was extended in the same way as that of **3a** in both solvents. However, other chloro-substituted compounds **3e--3g** had lower maximal absorption wavelengths and molar absorption coefficients than **3a** in all solvents. A bromo-substituent (**3h**) affected the absorption characteristics in a similar fashion to the chloro-substituent (**3e**). In contrast, the maximal absorption wavelength of **3j**, with a methyl substituent at position 3 of the isoindolo\[2,1-*a*\]quinoline, was red-shifted compared to that of **3e**. Particularly in MeOH, the maximal absorption wavelength of **3j** was extended up to 736 nm. The weaker absorption of benzo\[*g*\]quinoline derivative **3l** in CHCl~3~ was observed at a shorter wavelength. The maximal absorption wavelength of **3n**, with a *p*-methoxyphenyl substituent at the 11-position of the isoindolo\[2,1-*a*\]quinoline, was red-shifted compared to that of **3a**. Particularly in MeOH, the maximal absorption wavelength of **3n** was extended up to 737 nm. In contrast, the maximal absorption wavelength of **3o**, with a *p*-chlorophenyl substituent at the 11-position of the isoindolo\[2,1-*a*\]quinoline, was shorter than that of **3a**. An electron-donating group on the aromatic ring or heterocycle affected the maximum absorbance wavelength longer. Molar absorption coefficients were very low, that is, \<10 000.

![Absorption spectra of compounds **3** (250--1100 nm; 50 μM in CHCl~3~).](ao-2019-00315f_0008){#fig5}

![Absorption spectra of compounds **3** (250--1100 nm; 50 μM in MeOH).](ao-2019-00315f_0009){#fig6}

###### Maximal Absorption Wavelengths and Molar Absorption Coefficients of Compounds **3** (250--1100 nm; 50 μM in CHCl~3~ or MeOH)

                        CHCl~3~   MeOH                         
  -------- ------ ----- --------- ------- ------ ----- ------- ------
  **3a**   H      H     722       0.376   7530   726   0.301   6020
  **3d**   4-Cl   H     722       0.389   7770   727   0.258   5160
  **3e**   3-Cl   H     688       0.250   5010   698   0.258   5160
  **3f**   2-Cl   H     691       0.288   5760   688   0.239   3780
  **3g**   1-Cl   H     690       0.287   5740   673   0.161   3230
  **3h**   3-Br   H     685       0.301   6010   697   0.237   4750
  **3j**   3-Me   H     726       0.298   5960   736   0.255   5100
  **3l**                715       0.134   2690   715   0.134   2690
  **3n**   H      OMe   724       0.292   5833   737   0.119   2379
  **3o**   H      Cl    714       0.099   1971   717   0.132   2638

In addition, we calculated all the above compounds **3a**, **3d--h**, **3j**, **3l**, **3m,** and **3p** ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"})^[@ref13]^ in order to understand a structure and an absorption--wavelength relationships using time-dependent density functional theory (TD-DFT). All calculations were performed using Gaussian 09 (Rev. C) software. The ground-state geometries were optimized using the DFT method with B3LYP/6-31G(d). Harmonic frequency calculations were carried out to confirm that these geometries are stable with no imaginary frequencies. To obtain excited state energies, we calculated vertical excitation energies by the TD-DFT method with TD-B3LYP/6-31G(d). We compared experimental and calculated excitation energies in the electron volt unit. Although the calculated wavelength underestimated the experimental peak absorption wavelength, we found the linearity between the calculated and the experimental maximum absorption wavelength.

![Structure of **3p**. Absorption wavelength of **3p** is 663 nm.](ao-2019-00315f_0010){#fig7}

[Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"} shows the correlation between the calculated and the experimental absorption wavelength in CHCl~3~. In [Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}, the line is determined by the least squares method using the regression equation. *y* = 1.0*x* + *b*. The differences in calculated and experimental energies (1.7 vs 2.6 eV) might come from the shape and dyes' structures and charge-transfer band. According to the regression analysis ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}), the compounds outside the 95% confidence interval were **3a**, **3j**, **3g**, and **3p**. Especially, **3g** seems to be an outlier. The difference of **3g** from other compounds is that R^1^ is Cl-substituent. This big difference of experimental wavelength of **3g** and calculation might be caused by the repulsion between the Cl and phenyl group which can produce the distortion of the chromophore structure. These calculated results show that the TD-DFT approach is an effective method to understand the relationships between the structure and the absorption property.

![Correlation between experimental and calculated wavelength excitation energies.](ao-2019-00315f_0011){#fig8}

We investigated the absorption profiles of **3j** in various solvents in [Figure [9](#fig9){ref-type="fig"}](#fig9){ref-type="fig"}. A higher maximal absorption wavelength was observed for polar solvents, as shown in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, such as alcohol or DMSO. In dioxane, the maximal absorption wavelength was about 50 nm lower than that in MeOH. The molar absorption coefficient was stronger in CHCl~3~ and toluene than in other solvents.

![Absorption spectra of **3j** in various solvents (250--1100 nm; 50 μM).](ao-2019-00315f_0012){#fig9}

###### Maximal Absorption Wavelengths and Molar Absorption Coefficients of **3j** in Various Solvents (250--1100 nm; 50 μM)

            λ~ex~ (nm)   abs.    ε
  --------- ------------ ------- ------
  MeOH      736          0.255   5100
  EtOH      733          0.250   5010
  DMSO      732          0.247   4940
  CHCl~3~   726          0.298   5960
  DMF       722          0.239   4770
  CH~3~CN   709          0.231   4620
  acetone   707          0.247   4940
  AcOEt     697          0.239   4770
  toluene   693          0.262   5250
  dioxane   689          0.243   4850

Finally, we also synthesized 6-methylisoindolo\[2,1-*a*\]quinoline **5**, a novel isomer of the methyl substituent, from *N*-allyl-*N*-(2-methylallyl)-2-vinylaniline **4** via our one-pot strategy in 53% yield ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). The structure of **5** was determined by single-crystal X-ray diffraction ([Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}). According to X-ray diffraction, there is no steric repulsion between the methyl substituent at position 6 and the carbonyl group at position 6 of isoindolo\[2,1-*a*\]quinoline. Thus, isoindolo\[2,1-*a*\]quinoline chromophore of **5** has a planar structure.

![X-ray structure of 6-methylisoindolo\[2,1-*a*\]quinoline **5**.](ao-2019-00315f_0002){#fig10}

![Synthesis of 6-methylisoindolo\[2,1-*a*\]quinoline **5**](ao-2019-00315f_0016){#sch4}

A solution color of the 6-methylisoindolo\[2,1-*a*\]quinoline **5** in MeOH is red, although that of 5-methylisoindolo\[2,1-*a*\]quinoline **3a** is blue ([Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"}). As both compounds **3a** and **5** had the same core isoindolo\[2,1-*a*\] system, we considered that the methyl substituent's electronic effects to the pi-conjugate system were dramatically changed dependent on the methyl substituent's position on the pi-conjugate system. We then investigated the absorption profiles of compounds **3a** and **5** in MeOH ([Figure [12](#fig12){ref-type="fig"}](#fig12){ref-type="fig"}). The maximal absorption wavelength of compound **5** in MeOH was 474 nm. Compound **5** has no absorption in the NIR region. A molar absorption coefficient of **5** was 6730 M^--1^ cm^--1^, which is higher than that of **3a**. From these results, we surmised that the most important thing for absorbing light in the NIR region was the methyl substituent at position 5 of the isoindolo\[2,1-*a*\]quinoline chromophore.^[@ref15]^

![Colors of compound **3a** and **5** (50 μM in MeOH).](ao-2019-00315f_0003){#fig11}

![Absorption spectra of **3a** and **5** in MeOH (250--1100 nm; 50 μM).](ao-2019-00315f_0004){#fig12}

In summary, we synthesized isoindolo\[2,1-*a*\]quinoline derivatives **3d--3h**, **3j**, **3l**, **3n**, and **3o** as novel NIR absorption dyes and found that, among them, **3j** and **3n** were the red-shifted NIR dye in MeOH. We also found that the maximal absorption wavelength of isoindolo\[2,1-*a*\]quinolines **3** was affected by solvent polarity and that TD-DFT was effective to understand the structure and the absorption--wavelength relationships of **3**.

Experimental Section {#sec3}
====================

General Information {#sec3.1}
-------------------

Chemicals and solvents were either purchased from commercial suppliers or purified by standard techniques. All reactions were performed under a N~2~ atmosphere unless otherwise noted. For TLC, silica gel plates Merck 60 F~254~ were used. ^1^H NMR were recorded at 300, 400, and 500 MHz. ^13^C NMR spectra were recorded at 101 and 126 MHz. Chemical shifts are given in ppm relative to tetramethylsilane (TMS) and the coupling constants *J* are given in Hz. The spectra were recorded in CDCl~3~ as the solvent at room temperature unless otherwise noted. TMS served as the internal standard (δ = 0 ppm) for ^1^H NMR and CDCl~3~ was used as the internal standard (δ = 77.0 ppm) for ^13^C NMR. Column chromatography was performed with silica gel 60N (spherical, neutral, 63--210 μm, Kanto Chemical Co., Inc.), flash silica gel 60 (spherical, acid, 40--50 μm, Kanto Chemical Co., Inc.), and flash silica gel 60N (spherical, neutral, 40--50 μm, Kanto Chemical Co., Inc.) unless otherwise noted. Melting points were determined on the heated plate and are uncorrected. HRMS (*m*/*z*) was measured using a MALDI (matrix-assisted laser desorption/ionization)-TOF(time-of-flight) spectrometer unless otherwise noted. **3a**, **3b**, and **3c** are known compounds.^[@ref13]^

General Procedure for Preparation of *N*-Allyl-*N*-benzyl-*o*-isopropenylaniline **1** {#sec3.2}
--------------------------------------------------------------------------------------

### Procedure A for Synthesizing *N*-Benzyl-*o*-isopropenylaniline (Reductive Amination)^[@ref16]^ {#sec3.2.1}

To a solution of *o*-isopropenylaniline derivatives (1.0 equiv), PhCHO (1.2 equiv) and AcOH (1.2 equiv) in toluene (0.1 M) were added NaBH(OAc)~3~ (2.0 equiv) and the reaction mixture was stirred at rt for a while and then at refluxing temperature for 12 h. After the reaction mixture was cooled to 0 °C, saturated aqueous Na~2~CO~3~ was added to the reaction mixture. The organic compounds were extracted with AcOEt. The organic phases were washed with brine, dried over Na~2~SO~4~, and concentrated in vacuo. The obtained residue was prepurified by filtration through a short-pad silica gel with *n*-hexane/AcOEt = 24:1 as an eluent to give a crude compound containing *N*-benzyl-*o*-isopropenylaniline.

### Procedure B for Synthesis of *N*-Benzyl-*o*-isopropenylaniline (Alkylation) {#sec3.2.2}

A solution of *o*-isopropenylaniline derivatives (1.0 equiv) in THF (0.1 M) was cooled to −78 °C and was stirred. To a stirred mixture, *n*-BuLi (2.6 M in *n*-hexane, 1.0 equiv) was added dropwise and the whole mixture was stirred for 15 min. To a stirred mixture, BnBr (1.0 equiv) was added dropwise and the stirred mixture was warmed to rt. After 1 h, the reaction was quenched by the addition of water. The organic compounds were extracted with AcOEt. The organic phases were washed with brine, dried over Na~2~SO~4~, and concentrated in vacuo. The obtained residue was prepurified by filtration through a short-pad silica gel with *n*-hexane/AcOEt = 24:1 as an eluent to give a crude compound containing *N*-benzyl-*o*-isopropenylaniline.

### Synthesis of *N*-Allyl-*N*-benzyl-*o*-isopropenylaniline (Allylation) {#sec3.2.3}

A solution of crude *N*-benzyl-*o*-isopropenylaniline in 1,4-dioxane (0.5 M) was cooled to 0 °C and was stirred. To the stirred mixture, NaH (60% in mineral oil, 2.0 equiv) was added and the whole mixture was stirred for 15 min. To a stirred mixture, allyl bromide (2.0 equiv) and tetrabutyl ammonium fluoride (50 mol %) were added and the reaction mixture was stirred at 100 °C for 12 h. After the reaction mixture was cooled to 0 °C, saturated K~2~CO~3~ was added to the reaction mixture in MeOH. The organic compounds were extracted with AcOEt. The organic phases were washed with water, brine, dried over Na~2~SO~4~, and concentrated in vacuo. The obtained residue was subjected to column chromatography (neutral acid flash silica gel, *n*-hexane → *n*-hexane/AcOEt = 49:1) to give a colorless or brown oil.

### *N*-Allyl-*N*-benzyl-3-chloro-2-isopropenylaniline (**1d**) {#sec3.2.4}

Following the general procedure A, **1d** (706 mg, 2.37 mmol, 68%) was obtained as a yellow oil from **S1d** (587 mg, 3.50 mmol).

^1^H NMR (CDCl~3~, 400 MHz): δ 7.35--7.25 (5H, m), 7.16 (1H, dd, *J* = 8.2, 1.4 Hz), 7.12 (1H, dd, *J* = 7.8, 7.8 Hz), 6.96 (1H, dd, *J* = 7.8, 1.4 Hz), 5.79 (1H, ddt, *J* = 17.4, 9.6, 6.0 Hz), 5.45 (1H, s), 5.12 (1H, dt, *J* = 17.4, 1.4 Hz), 5.12 (1H, dt, *J* = 9.6, 1.4 Hz), 5.00 (1H, s), 4.18 (2H, br s), 3.60 (2H, d, *J* = 6.0 Hz), 2.18 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 101 MHz): δ 150.3, 142.1, 138.7, 138.3, 134.8, 133.2, 128.8, 128.1, 127.5, 127.0, 124.4, 121.1, 117.7, 117.5, 58.2, 55.3, 23.1; HRMS (MALDI): calcd for C~19~H~21~NCl, 298.1357 \[(M + H)^+^\]; found, 298.1354.

### *N*-Allyl-*N*-benzyl-4-chloro-2-isopropenylaniline (**1e**) {#sec3.2.5}

Following the general procedure A, **1e** (167 mg, 0.561 mmol, 56%) was obtained as a yellow oil from **S2e** (168 mg, 1.00 mmol).

^1^H NMR (CDCl~3~, 400 MHz): δ 7.29--7.20 (3H, m), 7.18--7.13 (3H, m), 7.09 (1H, ddd, *J* = 8.7, 2.7, 1.4 Hz), 6.80 (1H, d, *J* = 8.7 Hz), 5.74 (1H, ddt, *J* = 17.5, 10.8, 6.0 Hz), 5.15--5.05 (4H, m), 4.17 (2H, s), 3.57 (2H, d, *J* = 6.0 Hz), 2.21 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 101 MHz): δ 146.6, 146.5, 140.0, 137.8, 134.4, 130.1, 128.9, 128.2, 127.18, 127.15, 127.0, 122.4, 117.9, 115.5, 56.1, 54.4, 22.0; HRMS (MALDI): calcd for C~19~H~21~NCl, 298.1357 \[(M + H)^+^\]; found, 298.1354.

### *N*-Allyl-*N*-benzyl-5-chloro-2-isopropenylaniline (**1f**) {#sec3.2.6}

Following the general procedure A, **1f** (1.28 g, 4.30 mmol, 64%) was obtained as a yellow oil from **S2f** (1.13 g, 6.74 mmol).

^1^H NMR (CDCl~3~, 500 MHz): δ 7.31--7.28 (2H, m), 7.26--7.23 (1H, m), 7.22--7.19 (2H, m), 7.09 (1H, d, *J* = 8.1 Hz), 6.94 (1H, dd, *J* = 8.1, 1.8 Hz), 6.88 (1H, d, *J* = 1.8 Hz), 5.75 (1H, ddt, *J* = 16.6, 10.3, 6.6 Hz), 5.16--5.07 (4H, m), 4.22 (2H, s), 3.61 (2H, d, *J* = 6.6 Hz), 2.21 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 126 MHz): δ 149.2, 146.7, 137.8, 136.5, 134.0, 133.0, 131.3, 128.9, 128.2, 127.1, 122.1, 121.2, 118.1, 115.2, 55.7, 54.0, 22.0; HRMS (MALDI): calcd for C~19~H~21~NCl, 298.1357 \[(M + H)^+^\]; found, 298.1358.

### *N*-Allyl-*N*-benzyl-2-chloro-6-isopropenylaniline (**1g**) {#sec3.2.7}

Following the general procedure B, **1g** (122 mg, 0.409 mmol, 41%) was obtained as a yellow oil from **S2g** (168 mg, 1.00 mmol).

^1^H NMR (CDCl~3~, 400 MHz): δ 7.31--7.20 (6H, m), 7.00 (1H, s), 6.99 (1H, s), 5.87 (1H, ddt, *J* = 16.9, 10.1, 6.9 Hz), 5.13 (1H, d, *J* = 0.9 Hz), 5.12 (1H, d, *J* = 16.9 Hz), 5.00 (1H, d, *J* = 10.1 Hz), 4.79 (1H, d, *J* = 0.9 Hz), 4.25 (2H, br s), 3.75 (2H, d, *J* = 6.9 Hz), 2.06 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 101 MHz): δ 146.0, 145.7, 144.6, 139.3, 136.1, 134.3, 129.7, 128.9, 128.5, 128.0, 126.7, 125.5, 117.0, 115.3, 56.6, 55.8, 24.3; HRMS (MALDI): calcd for C~19~H~21~NCl, 298.1357 \[(M + H)^+^\]; found, 298.1353.

### *N*-Allyl-*N*-benzyl-4-bromo-2-isopropenylaniline (**1h**) {#sec3.2.8}

Following the general procedure A, **1h** (240 mg, 0.701 mmol, 70%) was obtained as a pale yellow oil from **S2h** (212 mg, 1.00 mmol).

^1^H NMR (CDCl~3~, 400 MHz): δ 7.31--7.20 (5H, m), 7.19--7.13 (2H, m), 6.74 (1H, d, *J* = 8.7 Hz), 5.73 (1H, ddt, *J* = 17.4, 10.2, 6.4 Hz), 5.14--5.06 (4H, m), 4.18 (2H, s), 3.57 (2H, d, *J* = 6.4 Hz), 2.21 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 101 MHz): δ 147.1, 146.5, 140.3, 137.8, 134.3, 132.9, 130.1, 128.8, 128.2, 127.0, 122.7, 117.9, 115.6, 114.9, 56.0, 54.3, 21.9; HRMS (MALDI): calcd for C~19~H~21~NBr, 342.0852 \[(M + H)^+^\]; found, 342.0851.

### *N*-Allyl-*N*-benzyl-2-isopropenyl-3-methylaniline (**1i**) {#sec3.2.9}

Following the general procedure A, **1i** (259 mg, 0.934 mmol, 52%) was obtained as a pale yellow oil from **S2i** (265 mg, 1.80 mmol).

^1^H NMR (CDCl~3~, 500 MHz, 60 °C): δ 7.29--7.23 (3H, m), 7.22--7.17 (1H, m), 7.09--7.03 (1H, m), 6.94--6.90 (2H, m), 5.77 (1H, ddt, *J* = 17.2, 10.9, 6.9 Hz), 5.31 (1H, d, *J* = 1.7 Hz), 5.05 (1H, d, *J* = 12.0 Hz), 5.02 (1H, dq, *J* = 1.7, 1.2 Hz), 4.79 (1H, d, *J* = 8.0 Hz), 4.79 (1H, s), 4.12 (2H, br s), 3.56 (2H, br s), 2.26 (3H, s, minor rotamer 2.27), 2.09 (3H, s, minor rotamer 2.11); ^13^C{^1^H} NMR (CDCl~3~, 101 MHz): δ 148.7, 144.5, 140.3, 139.0, 136.1, 135.5, 128.9, 128.0, 126.8, 126.5, 125.5, 120.2, 117.1, 115.8, 58.9, 55.3, 23.7, 20.4; HRMS (MALDI): calcd for C~20~H~24~N, 278.1903 \[(M + H)^+^\]; found, 278.1896.

### *N*-Allyl-*N*-benzyl-2-isopropenyl-4-methylaniline (**1j**) {#sec3.2.10}

Following the general procedure A, **1j** (88.8 mg, 0.320 mmol, 31%) was obtained as a pale yellow oil from **S2j** (151 mg, 1.03 mmol).

^1^H NMR (CDCl~3~, 400 MHz): δ 7.28--7.21 (5H, m), 7.00--6.94 (2H, m), 6.83 (1H, d, *J* = 7.8 Hz), 5.76 (1H, ddt, *J* = 16.9, 10.5, 6.4 Hz), 5.11--5.03 (4H, m), 4.15 (2H, s), 3.56 (2H, d, *J* = 6.4 Hz), 2.28 (3H, s), 2.24 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 101 MHz): δ 147.8, 145.7, 138.7, 138.6, 134.9, 131.8, 131.1, 129.0, 128.1, 128.0, 126.8, 121.1, 117.4, 114.5, 56.6, 54.5, 22.6, 20.6; HRMS (MALDI): calcd for C~20~H~24~N, 278.1903 \[(M + H)^+^\]; found, 278.1908.

### *N*-Allyl-*N*-benzyl-2-isopropenyl-4-methoxylaniline (**1k**) {#sec3.2.11}

Following the general procedure A, **1k** (613 mg, 2.09 mmol, 60%) was obtained as a pale yellow oil prepared from **S2h** (571 mg, 3.50 mmol).

^1^H NMR (CDCl~3~, 400 MHz): δ 7.29--7.25 (2H, m), 7.23--7.20 (3H, m), 6.87 (1H, d, *J* = 8.6 Hz), 6.75 (1H, d, *J* = 3.1 Hz), 6.71 (1H, dd, *J* = 8.6, 3.1 Hz), 5.77 (1H, ddt, *J* = 16.0, 11.0, 6.4 Hz), 5.12 (1H, s), 5.08 (1H, d, *J* = 11.0 Hz), 5.07 (1H, d, *J* = 16.0 Hz), 5.03 (1H, s), 4.09 (2H, s), 3.78 (3H, s), 3.51 (2H, d, *J* = 6.4 Hz), 2.25 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 126 Hz): δ 155.2, 147.5, 141.6, 140.8, 138.5, 135.1, 129.1, 128.0, 126.8, 122.6, 117.4, 115.7, 114.7, 112.1, 57.5, 55.4, 55.0, 22.8; HRMS (MALDI): calcd for C~20~H~24~NO, 294.1852 \[(M + H)^+^\]; found, 294.1847.

### *N*-Allyl-*N*-benzyl-3-isopropenylnaphthalen-2-amine (**1l**) {#sec3.2.12}

Following the general procedure A, **1l** (161 mg, 0.514 mmol, 41%) was obtained as a colorless solid from **S2i** (229 mg, 1.25 mmol).

^1^H NMR (CDCl~3~, 400 MHz): δ 7.73 (1H, d, *J* = 8.2 Hz), 7.64 (1H, d, *J* = 7.8 Hz), 7.64 (1H, s), 7.37 (1H, ddd, *J* = 7.8, 7.4, 1.4 Hz), 7.32 (1H, ddd, *J* = 8.2, 7.4, 1.4 Hz), 7.29--7.18 (5H, m), 7.21 (1H, s), 5.79 (1H, ddt, *J* = 17.0, 10.1, 6.4 Hz), 5.22 (1H, s), 5.18 (1H, q, *J* = 1.2 Hz), 5.11 (1H, d, *J* = 10.1 Hz), 5.11 (1H, dd, *J* = 17.0, 1.8 Hz), 4.33 (2H, s), 3.70 (2H, d, *J* = 6.4 Hz), 2.31 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 126 Hz): δ 147.8, 146.7, 139.2, 138.1, 134.5, 133.3, 129.7, 129.04, 128.97, 128.2, 127.4, 126.9, 126.5, 125.8, 124.2, 117.8, 117.4, 114.8, 56.1, 54.2, 22.7; HRMS (MALDI): calcd for C~23~H~24~N, 314.1903 \[(M + H)^+^\]; found, 314.1905; mp 90.5--91.0 °C (recrystallized from *n*-hexane/AcOEt, colorless column).

### *N*-Allyl-*N*-(4-methoxybenzyl)-2-isopropenylaniline (**1m**) {#sec3.2.13}

Following the general procedure A and allylation, **1m** (720 mg, 2.45 mmol, 49% in 2 steps) was obtained as a yellow oil from commercial isopropenylaniline (0.63 mL, 5.00 mmol).

^1^H NMR (CDCl~3~, 500 MHz): δ 7.18--7.13 (2H, m), 7.10 (2H, d, *J* = 8.6 Hz), 6.96 (1H, ddd, *J* = 5.7, 5.7, 1.0 Hz), 6.89 (1H, d, *J* = 8.0 Hz), 6.80 (2H, d, *J* = 8.6 Hz), 5.79--5.71 (1H, m) 5.10--5.02 (4H, m), 4.14(2H, s), 3.78 (3H, s), 3.58 (2H, d, *J* = 6.3 Hz), 2.23 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 126 Hz): δ 158.5, 148.2, 147.8, 138.6, 134.9, 130.4, 130.3, 130.1, 127.4, 122.3, 121.2, 117.4, 114.6, 113.4, 55.4, 55.2, 54.0, 22.3; HRMS (MALDI): calcd for C~20~H~24~NO, 294.1852 \[(M + H)^+^\]; found, 294.1851.

### *N*-Allyl-*N*-(4-chlorobenzyl)-2-isopropenylaniline (**1n**) {#sec3.2.14}

Following the general procedure A and allylation, **1n** (1.15 g, 3.85 mmol, 64% in 2 steps) was obtained as a yellow oil from commercial isopropenylaniline (0.85 mL, 6.00 mmol).

^1^H NMR (CDCl~3~, 400 MHz): δ 7.23 (2H, d, *J* = 8.3 Hz), 7.16 (2H, m), 7.12 (2H, d, *J* = 8.7 Hz), 6.97 (1H, dd, 8.0 Hz, 6.9 Hz), 6.87 Hz (1H, d, *J* = 6.9 Hz), 5.81--5.71 (1H, m), 5.12--5.06 (4H, m), 4.16 (2H, s), 3.58 (2H, d, *J* = 6.4 Hz), 2.22 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 126 Hz): δ 147.8, 147.6, 138.6, 136.8, 134.6, 132.5, 130.4, 130.2, 128.2, 127.5, 122.5, 121.1, 117.7, 114.8, 55.3, 54.5, 22.4; HRMS (MALDI): calcd for C~19~H~21~NCl, 298.1357 \[(M + H)^+^\]; found, 298.1356.

### General Procedure for Preparation of Isoindolo\[2,1-*a*\]quinoline **3** {#sec3.2.15}

To a solution of *N*-allyl-2-alkenylaniline derivatives **1** (1.0 equiv) in toluene (0.01 M) was added Grubbs II (1 mol %) and the reaction mixture was stirred at 80 °C for 10 min. After completion of the RCM (monitored by TLC), quinone (10 equiv) was added to the reaction mixture. The reaction mixture was stirred at 80 °C for another 30 min and then cooled to room temperature. To the reaction mixture saturated aqueous NH~4~Cl was added. The organic compounds were extracted with AcOEt. The organic phases were washed with brine, dried over Na~2~SO~4~, and concentrated in vacuo. The obtained residue was subjected to column chromatography (neutral flash silica gel, *n*-hexane/AcOEt = 9:1 → 3:1; 2nd time, *n*-hexane/toluene/AcOEt = 6:18:1) to give **3**.

### 4-Chloro-5-methyl-11-phenylisoindolo\[2,1-*a*\]quinoline-7,10-dione (**3d**) {#sec3.2.16}

Following the general procedure, **3d** (13.0 mg, 0.0350 mmol, 35%) was prepared obtained as a blue solid from **1d** (29.8 mg, 0.100 mmol).

^1^H NMR (CDCl~3~, 400 Hz): δ 9.06 (1H, d, *J* = 8.2 Hz), 7.45 (1H, dd, *J* = 8.2, 8.2 Hz), 7.40--7.30 (3H, m), 7.28--7.23 (1H, m), 6.99 (1H, d, *J* = 7.3 Hz), 6.88 (1H, d, *J* = 10.1 Hz), 6.76 (1H, d, *J* = 10.1 Hz), 6.53 (1H, d, *J* = 7.8 Hz), 6.27 (1H, d, *J* = 6.9 Hz), 4.96 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 101 MHz, 50 °C): δ 187.0, 184.7, 142.7, 142.2, 139.9, 138.2, 135.6, 134.5, 134.2, 134.1, 131.7, 130.4, 129.3, 128.2, 126.7, 118.3, 117.3, 111.0, 107.0, 105.6, 56.5; HRMS (MALDI): calcd for C~23~H~15~NO~2~Cl, 372.0776 \[(M + H)^+^\]; found, 372.0786; mp 172.0--173.0 °C (recrystallized from CHCl~3~, blue needle).

### 3-Chloro-5-methyl-11-phenylisoindolo\[2,1-*a*\]quinoline-7,10-dione (**3e**) {#sec3.2.17}

Following the general procedure, **3e** (15.7 mg, 0.0422 mmol, 42%) was obtained as a blue solid from **1e** (29.8 mg, 0.100 mmol).

^1^H NMR (CDCl~3~, 500 MHz): δ 7.48 (1H, d, *J* = 8.6 Hz), 7.37--7.32 (3H, m), 7.20 (2H, d, *J* = 7.4 Hz), 7.03 (1H, d, *J* = 7.4 Hz), 7.02 (1H, d, *J* = 10.3 Hz), 6.74 (1H, d, *J* = 10.3 Hz), 6.53 (1H, d, *J* = 9.2 Hz), 6.36 (1H, d, *J* = 7.4 Hz), 4.99 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 126 Hz): δ 186.3, 182.1, 142.1, 140.6, 138.5, 137.5, 136.8, 133.8, 133.52, 133.50, 131.1, 130.2, 129.3, 128.3, 126.5, 122.3, 122.2, 110.7, 107.2, 106.5, 56.8; HRMS (MALDI): calcd for C~23~H~14~NO~2~Cl, 371.0708 \[M^+^\]; found, 371.0705; mp 175.0--176.0 °C (recrystallized from CHCl~3~, blue needle).

### 2-Chloro-5-methyl-11-phenylisoindolo\[2,1-*a*\]quinoline-7,10-dione (**3f**) {#sec3.2.18}

Following the general procedure, **3f** (14.0 mg, 0.0376 mmol, 38%) was obtained as a blue solid from **1f** (29.8 mg, 0.100 mmol).

^1^H NMR (CDCl~3~, 400 MHz): δ 9.11 (1H, d, *J* = 1.8 Hz), 7.42--7.34 (3H, m), 7.30--7.23 (2H, m), 6.98 (1H, d, *J* = 7.3 Hz), 6.89 (1H, d, *J* = 10.3 Hz), 6.78 (1H, d, *J* = 10.3 Hz), 6.50 (1H, d, *J* = 1.8 Hz), 6.30 (1H, d, *J* = 7.3 Hz), 4.93 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 126 Hz, 60 °C): δ 186.5, 184.5, 142.6, 141.6, 140.9, 138.8, 137.7, 135.8, 134.7, 134.4, 133.8, 129.4, 128.7, 128.5, 126.9, 117.6, 116.6, 111.6, 107.6, 105.9, 56.6; HRMS (MALDI): calcd for C~23~H~14~NO~2~Cl, 371.0708 \[M^+^\]; found, 371.0694; mp 175.5--177.0 °C (recrystallized from CHCl~3~, blue needle).

### 1-Chloro-5-methyl-11-phenylisoindolo\[2,1-*a*\]quinoline-7,10-dione (**3g**) {#sec3.2.19}

Following the general procedure, **3g** (8.2 mg, 0.0221 mmol, 22%) was obtained as a blue solid from **1g** (29.8 mg, 0.100 mmol).

^1^H NMR (CDCl~3~, 500 MHz): δ 9.06 (1H, d, *J* = 9.7 Hz), 7.48 (1H, d, *J* = 9.7 Hz), 7.34--7.22 (5H, m), 6.89 (1H, d, *J* = 10.3 Hz), 6.79 (1H, d, *J* = 10.3 Hz), 6.78 (1H, s), 6.27 (1H, d, *J* = 7.4 Hz), 5.43 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 126 Hz): δ 186.5, 185.2, 142.4, 140.7, 140.4, 137.7, 136.8, 135.0, 134.7, 134.4, 132.5, 132.4, 128.9, 127.9, 127.0, 119.3, 119.2, 113.3, 112.5, 109.0, 58.5; HRMS (MALDI): calcd for C~23~H~14~NO~2~Cl, 371.0708 \[M^+^\]; found, 371.0699; mp 171.0--172.5 °C (recrystallized from CHCl~3~, blue needle).

### 3-Bromo-5-methyl-11-phenylisoindolo\[2,1-*a*\]quinoline-7,10-dione (**3h**) {#sec3.2.20}

Following the general procedure, **3h** (17.5 mg, 0.0420 mmol, 42%) was obtained as a blue solid from **1h** (34.2 mg, 0.100 mmol).

^1^H NMR (CDCl~3~, 400 MHz): δ 7.68 (1H, dd, *J* = 8.7, 1.4 Hz), 7.40--7.30 (3H, m), 7.21 (2H, d, *J* = 7.3 Hz), 7.05 (1H, dd, *J* = 6.6, 1.4 Hz), 7.03 (1H, d, *J* = 10.1 Hz), 6.75 (1H, d, *J* = 10.1 Hz), 6.47 (1H, dd, *J* = 8.7, 1.4 Hz), 6.41 (1H, dd, *J* = 7.3, 1.8 Hz), 5.01 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 126 Hz): δ 186.4, 181.7, 142.1, 140.3, 139.0, 137.43, 137.39, 136.7, 133.8, 133.6, 132.0, 131.3, 129.4, 129.3, 128.4, 126.50, 126.46, 126.40, 123.2, 110.8, 107.5, 106.8, 56.8; HRMS (MALDI): calcd for C~23~H~14~NO~2~Br, 415.0202 \[M^+^\]; found, 415.0202; mp 173.0--175.0 °C (recrystallized from AcOEt, blue needle).

### 3-Bromo-5-methyl-11-phenylisoindolo\[2,1-*a*\]quinoline-7,10-dione (**3j**) {#sec3.2.21}

Following the general procedure, **3j** (5.9 mg, 0.0168 mmol, 17%) was obtained as a green solid from **1j** (27.7 mg, 0.100 mmol).

^1^H NMR (CDCl~3~, 500 MHz): δ 7.39--7.31 (5H, m), 7.22 (2H, d, *J* = 7.4 Hz), 7.06 (1H, d, *J* = 7.4 Hz), 6.96 (1H, d, *J* = 10.3 Hz), 6.72 (1H, d, *J* = 10.3 Hz), 6.62 (1H, d, *J* = 8.0 Hz), 6.37 (1H, d, *J* = 7.4 Hz), 5.03 (3H, s), 2.11 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 126 MHz): δ 187.2, 182.7, 142.3, 141.5, 137.6, 137.5, 137.0, 134.4, 134.3, 133.4, 131.9, 130.2, 129.2, 128.1, 126.9, 126.5, 122.6, 110.3, 106.8, 106.1, 56.6, 24.1; HRMS (MALDI): calcd for C~24~H~17~NO~2~, 351.1254 \[M^+^\]; found, 351.1239; mp 181.0--182.0 °C (recrystallized from AcOEt, blue needle).

### 6-Methyl-14-phenylbenzo\[*g*\]isoindolo\[2,1-*a*\]quinoline-1,4-dione (**3l**) {#sec3.2.22}

Following the general procedure, **3l** (17.0 mg, 0.0439 mmol, 44%) was obtained as a green solid from **1l** (31.3 mg, 0.100 mmol).

^1^H NMR (CDCl~3~, 500 MHz): δ 7.91 (1H, d, *J* = 8.6 Hz), 7.52 (1H, d, *J* = 7.4 Hz), 7.51 (1H, s), 7.42 (1H, dd, *J* = 7.4, 7.4 Hz), 7.38--7.35 (2H, m), 7.33--7.28 (2H, m), 7.21 (1H, ddd, *J* = 6.9, 6.9, 1.2 Hz), 7.02 (1H, d, *J* = 10.0 Hz), 6.95 (1H, d, *J* = 7.4 Hz), 6.83 (1H, d, *J* = 10.0 Hz), 6.73 (1H, s), 6.18 (1H, d, *J* = 7.4 Hz), 4.99 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 126 MHz): δ 186.2, 184.9, 141.9, 140.2, 137.9, 136.4, 135.8, 135.0, 134.7, 134.6, 132.0, 129.9, 129.3, 129.2, 128.3, 128.1, 126.8, 126.6, 125.0, 123.7, 122.1, 114.3, 104.2, 103.9, 56.6; HRMS (MALDI): calcd for C~27~H~17~NO~2~, 387.1254 \[M^+^\]; found, 387.1269, mp 199.0--200.0 °C (recrystallized from CHCl~3~, green needle).

### 2-Chloro-5-methyl-13-phenylbenzo\[5,6\]isoindolo\[2,1-*a*\]quinoline-7,12-dione (**3m**) {#sec3.2.23}

Following the general procedure, **3m** (7.6 mg, 0.0180 mmol, 18%) was obtained as a blue solid from **1f** (29.8 mg, 0.100 mmol).

^1^H NMR (CDCl~3~, 500 MHz): δ 9.38 (1H, d, *J* = 1.8 Hz), 8.30 (1H, d, *J* = 6.4 Hz), 8.19 (1H, d, *J* = 7.3 Hz), 7.77 (1H, dd, *J* = 7.8, 1.4 Hz), 7.69 (1H, dd, *J* = 7.8, 1.4 Hz), 7.52 (1H, d, *J* = 5.0 Hz), 7.42--7.34 (3H, m), 7.27 (1H, s), 6.98 (1H, d, *J* = 7.3 Hz), 6.54 (1H, d, *J* = 1.8 Hz), 6.34 (1H, d, *J* = 7.3 Hz), 4.94 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 126 MHz): δ 183.2, 180.8, 141.6, 140.5, 139.5, 136.8, 136.6, 135.1, 134.5, 134.4, 134.0, 132.1, 131.3, 128.4, 127.8, 127.2, 126.4, 126.1, 125.2, 117.1, 115.2, 110.3, 106.8, 105.4, 55.0; HRMS (MALDI): calcd for C~27~H~16~NO~2~Cl, 421.0864 \[M^+^\]; found, 421.0861, mp 291.0--292.0 °C (recrystallized from DMSO, blue needle).

### 11-(4-Methoxyphenyl)-5-methylisoindolo\[2,1-*a*\]quinoline-7,10-dione (**3n**) {#sec3.2.24}

Following general procedure, **3n** (10.8 mg, 0.0294 mmol, 6%) was prepared as a blue solid from **1m** (149 mg, 0.500 mmol).

^1^H NMR (CDCl~3~, 400 MHz): δ 9.07 (1H, d, *J* = 8.7 Hz), 7.47 (1H, dd, *J* = 8.4, 7.8 Hz), 7.19 (2H, d, *J* = 8.7 Hz), 6.98 (1H, d, *J* = 7.4 Hz), 6.90 (2H, d, *J* = 8.7 Hz), 6.88 (1H, d, *J* = 8.6 Hz), 6.75 (1H, d, *J* = 10.1 Hz), 6.57 (1H, d, *J* = 8.2 Hz), 6.26 (1H, d, *J* = 7.3 Hz), 4,89 (3H, s), 3.79 (3H, s); ^13^C{^1^H} NMR (CDCl~3~, 101 MHz): δ 187.2, 184.6, 159.5, 142.9, 142.4, 139.8, 138.2, 134.1, 134.0, 131.8, 130.4, 128.1, 125.9, 117.8, 117.1, 114.6, 111.0, 107.0, 105.5, 56.1, 55.3, 29.7; HRMS (MALDI): calcd for C~24~H~17~NO~3~, 367.1208 \[M^+^\]; found, 367.1198; mp 254.0--255.0 °C (recrystallized from AcOEt, blue needle).

### 11-(4-Chlorophenyl)-5-methylisoindolo\[2,1-*a*\]quinoline-7,10-dione (**3o**) {#sec3.2.25}

Following general procedure, **3o** (8.3 mg, 0.022 mmol, 4%) was prepared as a blue solid from **1n** (149 mg, 0.500 mmol).

^1^H NMR (CDCl~3~, 400 MHz): δ 9.06 (1H, d, *J* = 8.7 Hz), 7.45 (1H, dd, *J* = 8.2, 8.7 Hz), 7.34 (2H, d, *J* = 8.7 Hz), 7.28 (1H, s), 7.20 (2H, d, 8.7 Hz), 6,96 (1H, d, 6.9 Hz), 6.89 (1H, d, 10.1 Hz), 6.77 (1H, d, 10.1 Hz), 6.45 (1H, d, 7.8 Hz), 6.27 (1H, d, 7.3 Hz), 4.92 (2H, s); ^13^C{^1^H} NMR (CDCl~3~, 100 MHz): δ 187.0, 184.8, 142.7, 142.1, 139.5, 138.1, 135.4, 134.10, 134.06, 132.9, 131.7, 130.3, 129.5, 127.9, 118.2, 117.3, 111.1, 107.2, 105.5, 56.0, 29.7; HRMS(MALDI): calcd for C~23~H~14~NO~2~Cl, 371.0713 \[M^+^\]; found, 371.0706; mp 275.0--276.0 °C (recrystallized from AcOEt, blue needle).

### *N*-Benzyl-*N*-(2-methylallyl)-2-vinylaniline (**4**) {#sec3.2.26}

To a solution of *N*-benzyl-2-vinylaniline^[@ref13]^ (88.0 mg, 0.598 mmol) in DMF (1.2 mL) was added 3-chloro-2-methyl-1-propene (117 μL, 1.20 mmol), K~2~CO~3~ (207 mg, 1.50 mmol) and TBAI (221 mg, 0.598 mmol) and the whole was stirred at 120 °C overnight. After the reaction mixture was cooled to rt, to the reaction mixture was added sat. K~2~CO~3~ in MeOH. The organic compounds were extracted with AcOEt. The organic phases were washed with water, brine, dried over Na~2~SO~4~ and concentrated in vacuo. The obtained residue was subjected to preparative gel permeation liquid chromatography (CHCl~3~) to give **4** (42.1 mg, 0.160 mmol, 27%) as a colorless oil.

^1^H NMR (CDCl~3,~ 500 MHz): δ 7.50 (1H, dd, *J* = 7.8, 1.4 Hz), 7.31--7.15 (6H, m), 7.12 (1H, ddd, *J* = 7.8, 7.8, 1.4 Hz), 7.00 (1H, dd, *J* = 7.8, 7.8 Hz), 6.89 (1H, dd, *J* = 7.8, 1.4 Hz), 5.69 (1H, dd, *J* = 17.9, 1.4 Hz), 5.26 (1H, dd, *J* = 11.0, 1.4 Hz), 4.93 (1H, s), 4.88 (1H, s), 4.14 (2H, s), 3.51 (2H, s), 1.72 (3H, s); ^13^C{^1^H} NMR (CDCl~3,~ 126 MHz, 60 °C): δ 149.2, 142.8, 138.4, 134.9, 133.3, 128.7, 128.1, 128.0, 127.9, 126.9, 126.8, 121.9, 113.4, 113.2, 59.2, 57.5, 20.8; HRMS (MALDI): calcd for C~19~H~22~N, 264.1747 \[(M + H)^+^\]; found, 264.1745.

### 6-Methyl-isoindolo\[2,1-*a*\]quinoline-7,10-dione (**5**) {#sec3.2.27}

To a solution of *N*-benzyl-*N*-(2-methylallyl)aniline derivatives **4** (27.7 mg, 0.100 mmol) in toluene (10 mL), Grubbs II (8.5 mg, 0.010 mmol) was added and the reaction mixture was stirred at 80 °C for 10 min. After completion of the RCM (monitored by TLC), 1,4-benzoquinone (108 mg, 1.00 mmol) was added to the reaction mixture. The reaction mixture was stirred at 80 °C for another 30 min and then cooled to room temperature. Saturated aqueous NH~4~Cl was added to the reaction mixture. The organic compounds were extracted with AcOEt. The organic phases were washed with brine, dried over Na~2~SO~4~, and concentrated in vacuo. The obtained residue was subjected to column chromatography (neutral flash silica gel, *n*-hexane/AcOEt = 9:1 → 3:1) to give **5** (17.8 mg, 0.0527 mmol, 53%) as a red solid.

^1^H NMR (CDCl~3,~ 500 MHz): δ 7.39--7.31 (5H, m), 7.22 (2H, d, *J* = 7.4 Hz), 7.06 (1H, d, *J* = 7.4 Hz), 6.96 (1H, d, *J* = 10.3 Hz), 6.72 (1H, d, *J* = 10.3 Hz), 6.62 (1H, d, *J* = 8.0 Hz), 6.37 (1H, d, *J* = 7.4 Hz), 5.03 (2H, s), 2.11 (3H, s); ^13^C{^1^H} NMR (CDCl~3,~ 126 MHz): δ 183.3, 181.2, 142.5, 138.2, 135.4, 134.1, 132.9, 132.8, 130.2, 129.6, 129.4, 128.9, 128.2, 127.5, 126.8, 126.5, 125.8, 121.8, 118.8, 113.0, 24.1; HRMS (MALDI): calcd for C~23~H~15~NO~2~, 337.1097 \[M^+^\]; found, 337.1098; mp 212.0--213.0 °C (recrystallized from *n*-hexane/AcOEt, red column).

Experiments for Photochemical Properties Measurements^[@ref17]^ {#sec3.3}
---------------------------------------------------------------

A 10 mM DMSO stock solution of each compound was prepared. Each spectrum was measured by using diluted stock solution of the desired solvent. A quartz cuvette containing the prepared solution was held on a cell holder placed in the light path of a monochromator. UV/vis/NIR spectra were recorded in the range from 250 to 1100 nm. The set-up parameters were as follows: UV/vis bandwidth: 2 nm, NIR bandwidth: 8 nm, UV/vis response: 0.06 s, NIR response: 0.06 s, path length: 1 cm, scan speed: 1000 nm/min, and grating and detector switch-over: 850 nm.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.9b00315](http://pubs.acs.org/doi/abs/10.1021/acsomega.9b00315).X-ray crystallographic information for **5** ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00315/suppl_file/ao9b00315_si_001.cif))Spectral data for all new compounds, material method for **1** and TD-DFT calculation of **3**, and X-ray crystallographic analysis of **5** ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00315/suppl_file/ao9b00315_si_002.pdf))

Supplementary Material
======================

###### 

ao9b00315_si_001.cif

###### 

ao9b00315_si_002.pdf

The authors declare no competing financial interest.

This work was partially supported by a Grant-in-Aid from JSPS Research Fellow (grant no. JP 16J05524), from JSPS KAKENHI (grant no. JP A16H010260) for Precisely Designed Catalysts with Customized Scaffolding, A262880510, T15K149760, and T15KT00630; the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT), JST ACT-C grant number JPMJCR12YM, Japan, AMED under grant number 17am0101084j0001 and Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials" from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
